MoonLake Immunotherapeutics’s Gross Margin at a glance
MoonLake Immunotherapeutics reports gross margin of 0% for Dec 2024. The prior period recorded 0% (Dec 2023). Year over year the metric moved +0 pts. The rolling three-period average stands at 0%. Data last refreshed Dec 7, 2025, 1:34 AM.
Latest reading
0% · Dec 2024
YoY movement
+0 pts
Rolling average
0%
Current Gross Margin
0%
+0 pts
–
Rolling average
0%
Latest Value
0%
Dec 2024
YoY Change
+0 pts
Absolute
YoY Change %
–
Rate of change
3-Period Avg
0%
Smoothed
Narrative signal
MoonLake Immunotherapeutics’s gross margin stands at 0% for Dec 2024. Year-over-year, the metric shifted by +0 pts, translating into a – rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How gross margin shapes MoonLake Immunotherapeutics's story
As of Dec 2024, MoonLake Immunotherapeutics reports gross margin of 0%. Measure pricing power and cost of goods efficiency by reviewing historical gross margins.
Pricing versus input costs
Gross margin expands when pricing power or mix more than offset raw material and labor inflation.
Benchmark to peers
Compare margins within a sector to spot operational advantages or signs of discounting.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
MoonLake Immunotherapeutics (MLTX) FAQs
Answers tailored to MoonLake Immunotherapeutics’s gross margin profile using the latest Financial Modeling Prep data.
What is MoonLake Immunotherapeutics's current gross margin?
As of Dec 2024, MoonLake Immunotherapeutics reports gross margin of 0%. This reading reflects the latest filings and price data for MLTX.
How is MoonLake Immunotherapeutics's gross margin trending year over year?
Year-over-year, the figure shifts by +0 pts. Pair this context with revenue growth and free cash flow signals to gauge momentum for MLTX.
Why does gross margin matter for MoonLake Immunotherapeutics?
Gross margin tracks the percentage of revenue remaining after direct production and service delivery costs. For MoonLake Immunotherapeutics, operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is MoonLake Immunotherapeutics's gross margin above its recent average?
MoonLake Immunotherapeutics's rolling three-period average sits at 0%. Comparing the latest reading of 0% to that baseline highlights whether momentum is building or fading for MLTX.
How frequently is MoonLake Immunotherapeutics's gross margin refreshed?
Data for MLTX was last refreshed on Dec 7, 2025, 1:34 AM and updates automatically every 24 hours, keeping your valuation inputs current.